Cargando…

In vivo imaging of therapy response to a novel Pan-HER antibody mixture using FDG and FLT positron emission tomography

PURPOSE: Overexpression of the human epidermal growth factor receptor (HER) family and their ligands plays an important role in many cancers. Targeting multiple members of the HER family simultaneously may increase the therapeutic efficacy. Here, we report the ability to image the therapeutic respon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nielsen, Carsten H., Jensen, Mette M., Kristensen, Lotte K., Dahlman, Anna, Fröhlich, Camilla, Jacobsen, Helle J., Poulsen, Thomas T., Lantto, Johan, Horak, Ivan D., Kragh, Michael, Kjaer, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741943/ https://www.ncbi.nlm.nih.gov/pubmed/26460961

Ejemplares similares

Simultaneous targeting of HER family pro-survival signaling with Pan-HER antibody mixture is highly effective in TNBC: a preclinical trial with PDXs
por: Reddy, Tejaswini P., et al.
Publicado: (2020)

CD4(+) and CD8a(+) PET imaging predicts response to novel PD-1 checkpoint inhibitor: studies of Sym021 in syngeneic mouse cancer models
por: Kristensen, Lotte K., et al.
Publicado: (2019)

[18F]FDG and [18F]FLT positron emission tomography imaging following treatment with belinostat in human ovary cancer xenografts in mice
por: Jensen, Mette Munk, et al.
Publicado: (2013)

(18)F-FDG and (18)F-FLT-PET Imaging for Monitoring Everolimus Effect on Tumor-Growth in Neuroendocrine Tumors: Studies in Human Tumor Xenografts in Mice
por: Bardram Johnbeck, Camilla, et al.
Publicado: (2014)

[18F]FLT and [18F]FDG PET for Non-invasive Treatment Monitoring of the Nicotinamide Phosphoribosyltransferase Inhibitor APO866 in Human Xenografts
por: Munk Jensen, Mette, et al.
Publicado: (2013)

Imaging of Treatment Response to the Combination of Carboplatin and Paclitaxel in Human Ovarian Cancer Xenograft Tumors in Mice Using FDG and FLT PET
por: Munk Jensen, Mette, et al.
Publicado: (2013)

Site-specifically labeled (89)Zr-DFO-trastuzumab improves immuno-reactivity and tumor uptake for immuno-PET in a subcutaneous HER2-positive xenograft mouse model
por: Kristensen, Lotte K., et al.
Publicado: (2019)

Early Detection of Response to Experimental Chemotherapeutic Top216 with [(18)F]FLT and [(18)F]FDG PET in Human Ovary Cancer Xenografts in Mice
por: Munk Jensen, Mette, et al.
Publicado: (2010)

HIV infection and arterial inflammation assessed by (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET): A prospective cross-sectional study
por: Knudsen, Andreas, et al.
Publicado: (2014)

Anti-tumoral activity of the Pan-HER (Sym013) antibody mixture in gemcitabine-resistant pancreatic cancer models
por: Rabia, Emilia, et al.
Publicado: (2021)

Usefulness of FDG, MET and FLT-PET Studies for the Management of Human Gliomas
por: Miyake, Keisuke, et al.
Publicado: (2012)

Use of Molecular Imaging Markers of Glycolysis, Hypoxia and Proliferation ((18)F-FDG, (64)Cu-ATSM and (18)F-FLT) in a Dog with Fibrosarcoma: The Importance of Individualized Treatment Planning and Monitoring
por: Zornhagen, Kamilla Westarp, et al.
Publicado: (2015)

Impact of [(18)F]FDG-PET and [(18)F]FLT-PET-Parameters in Patients with Suspected Relapse of Irradiated Lung Cancer
por: Christensen, Tine N., et al.
Publicado: (2021)

The Potential of panHER Inhibition in Cancer
por: Wang, Xiaochun, et al.
Publicado: (2015)

18F-FLT Positron Emission Tomography/Computed Tomography Imaging in Pancreatic Cancer: Determination of Tumor Proliferative Activity and Comparison with Glycolytic Activity as Measured by 18F-FDG Positron Emission Tomography/Computed Tomography Imaging
por: Debebe, Senait Aknaw, et al.
Publicado: (2016)

Antitumor activity of pan‐HER inhibitors in HER2‐positive gastric cancer
por: Yoshioka, Takahiro, et al.
Publicado: (2018)

(18)F-FDG positron emission tomography and diffusion-weighted magnetic resonance imaging for response evaluation of nanoparticle-mediated photothermal therapy
por: Simón, Marina, et al.
Publicado: (2020)

In Vivo Phenotyping of Tumor Metabolism in a Canine Cancer Patient with Simultaneous (18)F-FDG-PET and Hyperpolarized (13)C-Pyruvate Magnetic Resonance Spectroscopic Imaging (hyperPET): Mismatch Demonstrates that FDG may not Always Reflect the Warburg Effect
por: Gutte, Henrik, et al.
Publicado: (2015)

(18)F-FDG Positron Emission Tomography in Multifocal Pyomyositis
por: Harisankar, C. N. B., et al.
Publicado: (2012)

(18)F-FDG PET/CT-based early treatment response evaluation of nanoparticle-assisted photothermal cancer therapy
por: Norregaard, Kamilla, et al.
Publicado: (2017)

Non-invasive Early Response Monitoring of Nanoparticle-assisted Photothermal Cancer Therapy Using (18)F-FDG, (18)F-FLT, and (18)F-FET PET/CT Imaging
por: Jørgensen, Jesper Tranekjær, et al.
Publicado: (2018)

Assessment of muscle function using hybrid PET/MRI: comparison of (18)F-FDG PET and T2-weighted MRI for quantifying muscle activation in human subjects
por: Haddock, Bryan, et al.
Publicado: (2016)

Sym021, a promising anti-PD1 clinical candidate antibody derived from a new chicken antibody discovery platform
por: Gjetting, Torben, et al.
Publicado: (2019)

18F-FDG 18F-FDG Positron Emission Tomography Imaging of Cortical Reorganization in Spinal Trauma
por: Chopra, Jigyasa, et al.
Publicado: (2022)

Uptake of (18)FDG by a Hepatic Adenoma on Positron Emission Tomography
por: Stephenson, J. A., et al.
Publicado: (2011)

Microbial comparative pan-genomics using binomial mixture models
por: Snipen, Lars, et al.
Publicado: (2009)

A Boronate-Caged [(18)F]FLT Probe for Hydrogen Peroxide Detection Using Positron Emission Tomography
por: Carroll, Valerie, et al.
Publicado: (2014)

Noninvasive Molecular Imaging of the Enhanced Permeability and Retention Effect by (64)Cu-Liposomes: In vivo Correlations with (68)Ga-RGD, Fluid Pressure, Diffusivity and (18)F-FDG
por: Børresen, Betina, et al.
Publicado: (2020)

Quantitative PET imaging of PD-L1 expression in xenograft and syngeneic tumour models using a site-specifically labelled PD-L1 antibody
por: Christensen, Camilla, et al.
Publicado: (2019)

Correction: Christensen et al. Impact of [(18)F]FDG-PET and [(18)F]FLT-PET-Parameters in Patients with Suspected Relapse of Irradiated Lung Cancer. Diagnostics 2021, 11, 279
por: Christensen, Tine N., et al.
Publicado: (2022)

Positron Emission Tomography with [(18)F]FLT Revealed Sevoflurane-Induced Inhibition of Neural Progenitor Cell Expansion in vivo
por: Liu, Shuliang, et al.
Publicado: (2014)

The role of irreversible pan-HER tyrosine kinase inhibitors in the treatment of HER2-Positive metastatic breast cancer
por: Wu, Zihong, et al.
Publicado: (2023)

Assessment of response to neoadjuvant radiochemotherapy with F-18 FLT and F-18 FDG PET/CT in patients with rectal cancer
por: Rendl, Gundula, et al.
Publicado: (2014)

(18)F-FLT and (18)F-FDG PET/CT in Predicting Response to Chemoradiotherapy in Nasopharyngeal Carcinoma: Preliminary Results
por: Qi, Shi, et al.
Publicado: (2017)

Disseminated Skeletal Muscle and Cardiac Metastasis from Squamous Cell Carcinoma of the Lung Detected with FDG and FLT PET/CT
por: Jain, Tarun Kumar, et al.
Publicado: (2016)

A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in stages IB–IIIA resectable NSCLC
por: Crandall, John P., et al.
Publicado: (2017)

FLT-PET for the assessment of systemic sarcoidosis including cardiac and CNS involvement: a prospective study with comparison to FDG-PET
por: Martineau, Patrick, et al.
Publicado: (2020)

Direct inhibition of PI3K in combination with dual HER2 inhibitors is required for optimal antitumor activity in HER2+ breast cancer cells
por: Rexer, Brent N, et al.
Publicado: (2014)

Positron emission tomography of the vulnerable atherosclerotic plaque in man – a contemporary review
por: Pedersen, Sune F, et al.
Publicado: (2014)

Further Activation of FLT3 Mutants by FLT3 Ligand
por: Zheng, Rui, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_cgq4lspf0bumkhrnicqdud8bpe